|
Surmodics, Inc. (SRDX) DCF Valoración
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Surmodics, Inc. (SRDX) Bundle
¡Mejore sus estrategias de inversión con la calculadora DCF de Surmodics, Inc. (SRDX)! Explore los últimos datos financieros de Surmodics, ajuste las proyecciones y gastos de crecimiento, y observe instantáneamente cómo estas modificaciones afectan el valor intrínseco de Surmodics, Inc. (SRDX).
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 94.9 | 105.1 | 100.0 | 132.6 | 126.1 | 136.7 | 148.2 | 160.6 | 174.1 | 188.8 |
Revenue Growth, % | 0 | 10.83 | -4.93 | 32.65 | -4.91 | 8.41 | 8.41 | 8.41 | 8.41 | 8.41 |
EBITDA | 5.9 | 12.2 | -12.2 | 15.2 | 1.2 | 4.9 | 5.3 | 5.8 | 6.3 | 6.8 |
EBITDA, % | 6.26 | 11.58 | -12.23 | 11.43 | 0.94227 | 3.6 | 3.6 | 3.6 | 3.6 | 3.6 |
Depreciation | 7.5 | 8.3 | 9.7 | 9.2 | 8.7 | 10.7 | 11.7 | 12.6 | 13.7 | 14.8 |
Depreciation, % | 7.92 | 7.92 | 9.68 | 6.92 | 6.9 | 7.86 | 7.86 | 7.86 | 7.86 | 7.86 |
EBIT | -1.6 | 3.8 | -21.9 | 6.0 | -7.5 | -5.8 | -6.3 | -6.9 | -7.4 | -8.1 |
EBIT, % | -1.65 | 3.66 | -21.91 | 4.51 | -5.95 | -4.27 | -4.27 | -4.27 | -4.27 | -4.27 |
Total Cash | 61.1 | 38.9 | 19.0 | 45.4 | 40.1 | 51.0 | 55.2 | 59.9 | 64.9 | 70.4 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 16.2 | 22.9 | 24.2 | 23.9 | 23.2 | 27.2 | 29.5 | 32.0 | 34.6 | 37.6 |
Account Receivables, % | 17.05 | 21.79 | 24.21 | 18.03 | 18.37 | 19.89 | 19.89 | 19.89 | 19.89 | 19.89 |
Inventories | 6.0 | 6.8 | 11.8 | 14.8 | 15.2 | 13.1 | 14.2 | 15.3 | 16.6 | 18.0 |
Inventories, % | 6.29 | 6.43 | 11.82 | 11.19 | 12.03 | 9.55 | 9.55 | 9.55 | 9.55 | 9.55 |
Accounts Payable | 1.5 | 1.8 | 3.1 | 3.0 | .0 | 2.4 | 2.6 | 2.8 | 3.0 | 3.3 |
Accounts Payable, % | 1.6 | 1.7 | 3.14 | 2.26 | 0 | 1.74 | 1.74 | 1.74 | 1.74 | 1.74 |
Capital Expenditure | -3.7 | -6.3 | -3.4 | -2.9 | -3.5 | -5.0 | -5.4 | -5.8 | -6.3 | -6.9 |
Capital Expenditure, % | -3.87 | -5.97 | -3.37 | -2.2 | -2.77 | -3.64 | -3.64 | -3.64 | -3.64 | -3.64 |
Tax Rate, % | -53.77 | -53.77 | -53.77 | -53.77 | -53.77 | -53.77 | -53.77 | -53.77 | -53.77 | -53.77 |
EBITAT | 1.2 | 2.6 | -26.5 | -3.7 | -11.5 | -3.1 | -3.4 | -3.7 | -4.0 | -4.3 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -15.6 | -2.7 | -25.2 | -.3 | -8.9 | 3.1 | -.3 | -.3 | -.3 | -.4 |
WACC, % | 9.55 | 9.95 | 10.15 | 9.55 | 10.15 | 9.87 | 9.87 | 9.87 | 9.87 | 9.87 |
PV UFCF | ||||||||||
SUM PV UFCF | 1.9 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | -5 | |||||||||
Present Terminal Value | -3 | |||||||||
Enterprise Value | -1 | |||||||||
Net Debt | -3 | |||||||||
Equity Value | 2 | |||||||||
Diluted Shares Outstanding, MM | 14 | |||||||||
Equity Value Per Share | 0.12 |
What You Will Get
- Real SRDX Financial Data: Pre-filled with Surmodics, Inc.’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Surmodics, Inc.’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Surmodics, Inc. (SRDX).
- WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet with adjustable inputs specific to Surmodics, Inc. (SRDX).
- Customizable Forecast Assumptions: Easily modify growth rates, capital expenditures, and discount rates for accurate projections.
- Integrated Financial Ratios: Assess profitability, leverage, and efficiency ratios relevant to Surmodics, Inc. (SRDX).
- Interactive Dashboard and Charts: Visual representations highlight key valuation metrics for straightforward analysis.
How It Works
- Download: Get the pre-prepared Excel file containing Surmodics, Inc.'s (SRDX) financial data.
- Customize: Modify projections, including revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various forecasts and compare results immediately.
- Make Decisions: Utilize the valuation outcomes to inform your investment strategy.
Why Choose This Calculator for Surmodics, Inc. (SRDX)?
- Accurate Data: Utilize real Surmodics financials for trustworthy valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-configured calculations save you the hassle of starting from the ground up.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants focused on Surmodics.
- User-Friendly: Easy-to-navigate design and clear instructions cater to users of all experience levels.
Who Should Use Surmodics, Inc. (SRDX)?
- Healthcare Professionals: Understand the latest advancements in medical device technologies and their applications.
- Researchers: Utilize data from Surmodics, Inc. (SRDX) to enhance studies in drug delivery systems.
- Investors: Analyze market trends and evaluate investment opportunities related to Surmodics, Inc. (SRDX).
- Business Analysts: Leverage customizable financial models to assess Surmodics, Inc. (SRDX) performance.
- Medical Device Entrepreneurs: Gain insights into the strategies used by established companies like Surmodics, Inc. (SRDX).
What the Template Contains
- Pre-Filled Data: Includes Surmodics, Inc.'s (SRDX) historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Surmodics, Inc.'s (SRDX) profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.